RAS Nanoclusters: Dynamic Signaling Platforms Amenable to Therapeutic Intervention

Area of Science:

• Molecular biology
• Cell signaling
• Cancer research

Background:

• RAS proteins are critical regulators of cell signaling, acting as molecular switches.
• Mutations in RAS proteins are common in cancer (approx. 20%) and linked to poor prognosis.
• RAS proteins localize to the plasma membrane and form dynamic assemblies called nanoclusters.

Purpose of the Study:

• To review the clustering behavior of RAS proteins and the interfaces involved.
• To discuss the role of RAS nanoclusters in signal transduction.
• To explore therapeutic strategies targeting RAS nanocluster formation or stabilization.

Main Methods:

• Literature review of studies on RAS protein behavior, nanocluster formation, and signaling.
• Analysis of protein-protein and protein-lipid interactions stabilizing RAS nanoclusters.
• Discussion of potential therapeutic interventions based on nanocluster modulation.

Main Results:

• RAS proteins exhibit a propensity for forming dynamic nanoclusters at the plasma membrane.
• These nanoclusters are stabilized by weak protein-protein and protein-lipid interactions.
• Disruption of RAS nanoclusters leads to reduced RAS-mediated mitogenic signaling.

Conclusions:

• RAS nanoclusters are key functional units regulating RAS signaling.
• Targeting the disruption of nanocluster formation or stabilizing inactive RAS complexes presents a promising therapeutic avenue for cancers driven by RAS mutations.